Advisor Group Holdings, Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.12 - $0.64 $240 - $1,280	-2,000 Reduced 16.67%	10,000 $2,000
Q3 2023 Nov 13, 2023	SELL	$0.12 - $0.41 $120 - $410	-1,000 Reduced 7.69%	12,000 $1,000
Q2 2023 Aug 10, 2023	SELL	$0.35 - $0.72 $420 - $864	-1,200 Reduced 8.45%	13,000 $4,000
Q1 2023 May 12, 2023	SELL	$0.39 - $0.6 $6,630 - $10,200	-17,000 Reduced 54.49%	14,200 $6,000
Q1 2022 May 04, 2022	BUY	$0.5 - $1.06 $2,500 - $5,300	5,000 Added 19.08%	31,200 $25,000
Q3 2021 Nov 05, 2021	BUY	$0.67 - $1.51 $2,680 - $6,040	4,000 Added 18.02%	26,200 $34,000
Q1 2021 May 13, 2021	BUY	$0.96 - $1.74 $2,112 - $3,828	2,200 Added 11.0%	22,200 $23,000
Q3 2020 Nov 12, 2020	BUY	$0.67 - $0.96 $9,380 - $13,440	14,000 Added 233.33%	20,000 $15,000
Q1 2020 May 18, 2020	BUY	$0.6 - $2.31 $3,600 - $13,860	6,000 New	6,000 $4,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.